Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
N/A
18 Years
N/A
18 Years
N/A
Not Enrolling
Both
Carcinoma, Hepatocellular
Both
Carcinoma, Hepatocellular
Trial Information
Global Investigation of Therapeutic Decisions in Hepatocellular Carcinoma and of Its Treatment With Sorafenib
Inclusion Criteria:
- Outpatients with histologically/cytologically documented or radiographically
diagnosed unresectable HCC who are candidates for systemic therapy and for whom a
decision to treat with Nexavar has been made. Radiographic diagnosis HCC NIS, needs
typical findings of HCC by radiographic method i.e. on multi-dimensional, dynamic CT,
CT hepatic arteriography (CTHA)/CT arterial portography (CTAP), or MRI.
- Patients must have signed an informed consent form
- Patients must have a life expectancy of at least 8 weeks
Exclusion Criteria:
- Exclusion criteria must follow the approved local product information
Type of Study:
Observational
Study Design:
Observational Model: Cohort, Time Perspective: Prospective
Outcome Measure:
The safety of Nexavar in all patients with unresectable HCC who are candidates for systemic therapy and in whom a decision to treat with Nexavar has been made under real-life practice conditions
Outcome Time Frame:
at each follow-up visit, every 2-4 months on average
Safety Issue:
Yes
Principal Investigator
Bayer Study Director
Investigator Role:
Study Director
Investigator Affiliation:
Bayer
Authority:
China: Ethics Committee
Study ID:
13414
NCT ID:
NCT00812175
Start Date:
January 2009
Completion Date:
April 2012
Related Keywords:
- Carcinoma, Hepatocellular
- Hepatocellular Carcinoma
- HCC
- Sorafenib
- Carcinoma
- Carcinoma, Hepatocellular
Name | Location |
|---|---|
| Hinsdale, Illinois 60521 | |
| New Britain, Connecticut 06052 | |
| Bettendorf, Iowa 52722 | |
| Alexandria, Minnesota 56308 | |
| Albany, Georgia 31701 | |
| Birmingham, Alabama 35294 | |
| Phoenix, Arizona 85012 | |
| Fountain Valley, California 92708 | |
| Miami, Florida 33176 | |
| Columbia, Missouri 65203 | |
| Albany, New York 12208 | |
| Cleveland, Ohio 44195 | |
| Philadelphia, Pennsylvania 19104 | |
| Nashville, Tennessee 37203-1632 | |
| Austin, Texas 78705 | |
| Seattle, Washington 98195 | |
| Flint, Michigan 48532 | |
| Louisville, Kentucky 40207 | |
| McLean, Virginia 22101 | |
| Little Rock, Arkansas 72205-7199 | |
| Kansas City, Kansas 66160 | |
| Omaha, Nebraska 68114 | |
| Hackensack, New Jersey 07601 | |
| Metairie, Louisiana 70006 | |
| Denver, Colorado | |
| Baltimore, Maryland 21287 | |
| Boston, Massachusetts | |
| Charlotte, North Carolina | |
| Eugene, Oregon | |
| Milwaukee, Wisconsin | |
| Indianapolis, Indiana | |
| Charleston, South Carolina | |
| Lebanon, New Hampshire | |
| Tulsa, Oklahoma | |
| Honolulu, Hawaii 96813 | |
| Las Vegas, Nevada 89109 | |
| Salt Lake City, Utah 84112 |
